Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Shares Outstanding (Diluted Average): 2022-2023

Historic Shares Outstanding (Diluted Average) for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $2.0 million.

  • Therapeutics' Shares Outstanding (Diluted Average) fell 96.45% to $2.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.0 million, marking a year-over-year decrease of 96.45%. This contributed to the annual value of $54.9 million for FY2022, which is N/A change from last year.
  • As of Q3 2023, Therapeutics' Shares Outstanding (Diluted Average) stood at $2.0 million, which was up 0.29% from $2.0 million recorded in Q2 2023.
  • Over the past 5 years, Therapeutics' Shares Outstanding (Diluted Average) peaked at $55.2 million during Q3 2022, and registered a low of $2.0 million during Q1 2023.
  • For the 2-year period, Therapeutics' Shares Outstanding (Diluted Average) averaged around $32.1 million, with its median value being $54.0 million (2022).
  • Data for Therapeutics' Shares Outstanding (Diluted Average) shows a maximum YoY tumbled of 96.45% (in 2023) over the last 5 years.
  • Therapeutics' Shares Outstanding (Diluted Average) (Quarterly) stood at $54.9 million in 2022, then crashed by 96.45% to $2.0 million in 2023.
  • Its Shares Outstanding (Diluted Average) stands at $2.0 million for Q3 2023, versus $2.0 million for Q2 2023 and $2.0 million for Q1 2023.